top of page

Fall 2021 Kickoff; Dr. Paul Huston, Research in Psychoactive Substances

Club Announcements


Objectives

  • Want to pursue a PharmD or PharmTox Undergrad curriculum (or just curious?)

  • Guest speakers - pharmacists, pharmacy students, admissions advisors, resume workshops etc.

  • Volunteer in the community and have club socials like our “Study Jams”

  • Meet other undergraduates interested in pharmacy!


Fall 2021 Executive Board

  • President- Katie Oswald

  • Secretary- Reem Salah

  • Volunteer Coordinator- Emily Sitte

  • Treasurer/Outreach Chair- Tracy Wang


Freshman Representative!

  • duties include:

    • Give insight to the needs/wishes of the freshman class and new club members

    • Assist the volunteer coordinator with event organization

    • Help the secretary take meeting minutes

    • Other miscellaneous tasks


Application link here


Applications are due by MIDNIGHT OF OCTOBER 22nd


Membership Requirements

  • *No dues this semester*

  • No point system this semester


Other Opportunities & Volunteering

  • Check out other opportunities posted on our website! Website>More>Other Opportunities

  • Check out volunteering opportunities posted on our website! Website> Volunteer Events


Mentorship Program

  • Build a one-on-one connection with a current Pharmacy student!

  • Undergrads will be matched with 2nd or 3rd year pharmacy students

  • Matches based on career interests

  • Sign up link here

  • First Wave Due date: October 6th at 11:59 pm

  • Questions?


Next Event!

  • First General Meeting; Thursday, October 7th From 6-7:15PM

    • Roundtable discussion with current pharmacy students!


Professor Paul Hutson

Transdisciplinary Center for Research in Psychoactive Substances


Background info here


Who am I?

  • From Long Beach, CA

  • Faculty member at SOP (School of Pharmacy)

  • Teaching

    • Pharmacokinetics

    • Pediatrics

    • Oncology

    • Psychedelics in Science and Society

  • 5 years at University of Illinois in Chicago, 33 years at Madison SOP


Clinical Practice

  • Adult cancer

  • Palliative care (symptom management)


What are we up to?

  • Dose escalation of psilocybin in normal adults

  • Psilocybin for patients with major depression

  • MDMA (Ecstasy) in the treatment of PTSD


Psilocybin

  • Obtained from ingestion of shrooms

  • Using pure psilocybin

  • Have been used for thousands of years in multiple civilizations


Why Psilocybin?

  • Establishes & maintains a mystical state, but not as long as LSD

    • Noetic: insight , awareness

    • Unity: one with others, the universe

    • Ineffable: experience cannot be describes

    • Positive mood

    • Transcendent of TIme and Space

    • Ego dissolution: Loss of self


How does it work?

  • Psychedelics Gives brain better opportunity to communicate with itself

Exclusions

  • Some psychiatric illnesses

    • Schizofrenia

    • Mania, bipolar

  • Depression that cannot allow discontinuation of antidepressants


Set and Setting Safety

  • Screening subjects

  • Several preparation sessions

  • Eight-hour dosing session monitored by professionals

  • Next-day integration session

  • Side effects are mild

  • Found that the drug was well tolerated in UW study


Ethnic and racial minorities are underrepresented in the research and in the research staff- work needs to be done to make sure all populations are accounted for in all studies and research.


Current Phase 1 Study-

Study of safety of effects of Psilocybin on former patients addicted to Opioids and/or on/ have had Suboxone treatment


Contact:


Paul Hutson, PharmD, MS


Cody Wenthur, PharmD, PHD

  • wenthur@wisc.edu

  • Phone:(608) 265-6743

Comments

Single post: Blog_Single_Post_Widget
bottom of page